Biosketch / Results /

Daniel C Cho

Assistant Professor;
Department of Medicine (Medicine)

Clinical Addresses

160 E. 34TH STREET
NEW YORK, NY 10016
Handicap Access: yes
Phone: 212-731-5445

« Back to Results

Medical Specialties

Hematology, Medical Oncology

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AFFINITY, CIGNA EPO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GHI CBP, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP HMO, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, METROPLUS CHLD HLTH, METROPLUS FAM HLTH, MULTIPLAN/PHCS PPO, Medicare, MetroPlus Medicaid, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, Tricare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS, WELLCARE CHLD HLTH, WELLCARE FAM HLTH, WELLCARE MEDICAID, WELLCARE MEDICARE

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2003 — Ab Internal Medicine - Internal Medicine
2006 — Ab Internal Medicine (Medical Oncology)

Education

1996-2000 — Washington University in St. Louis School of Medicine, Medical Education
2000-2001 — Beth Israel Deaconess Med Ctr (Internal Medicine), Internship
2000-2001 — Beth Israel Deaconess Med Ctr (No Value Specified), Internship
2000-2003 — Beth Israel Deaconess Med Ctr (No Value Specified), Internship
2001-2002 — Beth Israel Deaconess Med Ctr (No Value Specified), Residency Training
2001-2003 — Beth Israel Deaconess Med Ctr (Internal Medicine), Residency Training
2002-2003 — Beth Israel Deaconess Med Ctr (No Value Specified), Clinical Fellowships
2003-2006 — Beth Israel Deaconess Med Ctr (No Value Specified), Clinical Fellowships

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors
Cho, Daniel C
2013 ;6:679-684, OncoTargets & therapy
— id: 674202, year: 2013, vol: 6, page: 679, stat: Journal Article,

Therapeutic challenges in advanced renal cell carcinoma
Cho, Daniel C
2013 Jan;10(1):39-46, Clinical practice
— id: 674252, year: 2013, vol: 10, page: 39, stat: Journal Article,

Dual inhibition of PI3-kinase and mTOR in renal cell carcinoma
Cho, Daniel C; Mier, James W
2013 Feb;13(2):126-142, Current cancer drug targets
— id: 674232, year: 2013, vol: 13, page: 126, stat: Journal Article,

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
Ghamande, Sharad; Lin, Chia-Chi; Cho, Daniel C; Shapiro, Geoffrey I; Kwak, Eunice L; Silverman, Michael H; Tseng, Yunlong; Kuo, Min-Wen; Mach, Wendy B; Hsu, Shu-Chi; Coleman, Teresa; Yang, James Chih-Hsin; Cheng, Ann-Lii; Ghalib, Mohammad H; Chuadhary, Imran; Goel, Sanjay
2013 Nov;:445-451, Investigational new drugs
— id: 674182, year: 2013, vol: , page: 445, stat: Journal Article,

Vemurafenib-induced cardiac tamponade: a rare but potentially life-threatening complication
Mahoney, Kathleen M; Ackerman, Allison; Cho, Daniel C; McDermott, David F; Peters, Toni; Atkins, Michael B
2013 Jul;31(21):e364-e366, Journal of clinical oncology
— id: 674192, year: 2013, vol: 31, page: e364, stat: Journal Article,

Perifosine in renal cell carcinoma
Srivastava, Neeharika; Cho, Daniel C
2013 Feb;22(2):285-291, Expert opinion on investigational drugs
— id: 674242, year: 2013, vol: 22, page: 285, stat: Journal Article,

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement
Tabernero, Josep; Shapiro, Geoffrey I; LoRusso, Patricia M; Cervantes, Andres; Schwartz, Gary K; Weiss, Glen J; Paz-Ares, Luis; Cho, Daniel C; Infante, Jeffrey R; Alsina, Maria; Gounder, Mrinal M; Falzone, Rick; Harrop, Jamie; White, Amy C Seila; Toudjarska, Iva; Bumcrot, David; Meyers, Rachel E; Hinkle, Gregory; Svrzikapa, Nenad; Hutabarat, Renta M; Clausen, Valerie A; Cehelsky, Jeffrey; Nochur, Saraswathy V; Gamba-Vitalo, Christina; Vaishnaw, Akshay K; Sah, Dinah W Y; Gollob, Jared A; Burris, Howard A 3rd
2013 Apr;3(4):406-417, Cancer discovery
— id: 674212, year: 2013, vol: 3, page: 406, stat: Journal Article,

PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells
Zhu, Shudong; Cohen, Matthew B; Bjorge, Jeffrey D; Mier, James W; Cho, Daniel C
2013 Mar;17(3):377-385, Journal of cellular & molecular medicine
— id: 674222, year: 2013, vol: 17, page: 377, stat: Journal Article,

Serum cholesterol and mTOR inhibitors: surrogate biomarker or epiphenomenon?
Cho, Daniel C; Atkins, Michael B
2012 Jun;18(11):2999-3001, Clinical cancer research
— id: 674282, year: 2012, vol: 18, page: 2999, stat: Journal Article,

Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy
Cho, Daniel C; Hutson, Thomas E; Samlowski, Wolfram; Sportelli, Peter; Somer, Brad; Richards, Paul; Sosman, Jeffrey A; Puzanov, Igor; Michaelson, M Dror; Flaherty, Keith T; Figlin, Robert A; Vogelzang, Nicholas J
2012 Dec;118(24):6055-6062, Cancer
— id: 674262, year: 2012, vol: 118, page: 6055, stat: Journal Article,

Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome
Dabydeen, Donnette A; Jagannathan, Jyothi P; Ramaiya, Nikhil; Krajewski, Katherine; Schutz, Fabio A B; Cho, Daniel C; Pedrosa, Ivan; Choueiri, Toni K
2012 Jul;48(10):1519-1524, European journal of cancer (1990)
— id: 674272, year: 2012, vol: 48, page: 1519, stat: Journal Article,

mTOR inhibitors in renal cell carcinoma
Battelli, Chiara; Cho, Daniel C
2011 Jul;8(4):359-367, Therapy
— id: 674322, year: 2011, vol: 8, page: 359, stat: Journal Article,

Future directions in renal cell carcinoma: 2011 and beyond
Cho, Daniel C; Atkins, Michael B
2011 Aug;25(4):917-935, Hematology-oncology clinics of North America
— id: 674312, year: 2011, vol: 25, page: 917, stat: Journal Article,

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma
Elfiky, Aymen A; Cho, Daniel C; McDermott, David F; Rosenberg, Jonathan E; Fortner, Barry; Antras, Lucia; Chen, Kristina; Sheng Duh, Mei; Jayawant, Sujata S; Oh, William K; Atkins, Michael B; Choueiri, Toni K
2011 Nov-Dec;29(6):756-763, Urologic oncology
— id: 674292, year: 2011, vol: 29, page: 756, stat: Journal Article,

Addition of gemcitabine at the time of sunitinib resistance in metastatic renal cell cancer
Pandya, Shuchi S; Mier, James W; McDermott, David F; Cho, Daniel C
2011 Oct;108(8 Pt 2):E245-E249, BJU international
— id: 674302, year: 2011, vol: 108, page: E245, stat: Journal Article,

The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma
Cho, Daniel C; Cohen, Matthew B; Panka, David J; Collins, Michael; Ghebremichael, Musie; Atkins, Michael B; Signoretti, Sabina; Mier, James W
2010 Jul;16(14):3628-3638, Clinical cancer research
— id: 674342, year: 2010, vol: 16, page: 3628, stat: Journal Article,

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy
Choueiri, Toni K; Regan, Meredith M; Rosenberg, Jonathan E; Oh, William K; Clement, Jessica; Amato, Angela M; McDermott, David; Cho, Daniel C; Atkins, Michael B; Signoretti, Sabina
2010 Sep;106(6):772-778, BJU international
— id: 674332, year: 2010, vol: 106, page: 772, stat: Journal Article,

Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma
Cho, Daniel C; Puzanov, Igor; Regan, Meredith M; Schwarzberg, Talya; Seery, Virginia; Lee, Mee-Young; Liu, Vivian; Bhatt, Rupal; Koon, Henry; Mier, James W; Sosman, Jeffrey A; Atkins, Michael B; McDermott, David F
2009 Feb-Mar;32(2):181-185, Journal of immunotherapy (Hagerstown)
— id: 674352, year: 2009, vol: 32, page: 181, stat: Journal Article,

GSK-3beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines
Panka, David J; Cho, Daniel C; Atkins, Michael B; Mier, James W
2008 Jan;283(2):726-732, Journal of biological chemistry
— id: 674362, year: 2008, vol: 283, page: 726, stat: Journal Article,